Navigation Links
New Editor Named for Prestigious Journal of Vascular and Interventional Radiology
Date:1/27/2010

rtment at the Hospital of the University of Pennsylvania in Philadelphia as an assistant professor in 1992. In 1999, he moved to Columbia University, New York City, as a full professor and director of the Division of Vascular and Interventional Radiology at the New York-Presbyterian Hospital. Since the fall of 2008, he has been at University of Maryland Medical Center.

Since 1994, Haskal has chaired or served on many SIR, American Heart Association, Radiological Society of North America and American College of Radiology committees. In 2007, he chaired the SIR Annual Scientific Meeting in Seattle, Wash. He is a co-founder and co-director of the Global Embolization Symposium and Technologies (GEST) scientific meeting. He has held a long-standing role as editor and then deputy editor-in-chief of CardioVascular and Interventional Radiology as well as editorial board and reviewer positions for more than 10 other peer-reviewed journals. During his editorial tenure, the impact factor of CVIR has nearly doubled.

Haskal has authored more than 165 peer-reviewed articles, chapters, books, reviews and editorials and has published more than 120 scientific abstracts. He has delivered more than 450 invited national and international scientific lectures and has led or participated in more than 30 externally sponsored clinical or animal research trials.

Since Nemcek, an interventional radiologist and professor of radiology and surgery at Northwestern Memorial Hospital in Chicago, Ill., became editor in 2005, JVIR has achieved international recognition as a leading interventional radiology journal. JVIR was recently ranked in the top half of 90 journals in radiology, nuclear medicine and medical imag
'/>"/>

SOURCE Society of Interventional Radiology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Editorial says primary care system must change how it approaches dementia
2. Boiron Laboratories Disputes British Journals Editorial on Homeopathy
3. The Top 10 Health Stories of 2007, From the Editors of the Harvard Health Letter
4. NEJM editorial on significance and limitations of new lupus gene expression research
5. Journal of Opioid Management Welcomes New Editor-in-Chief!
6. JAMA editor-in-chief comments on Pfizer lawsuit
7. Spry Names Lisa Delaney Editor in Chief
8. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
9. Award Winning Vanity Fair Contributing Editor Judy Bachrach Launches TheCheckoutLine.org - An Advice Column on Dying Well
10. The Inhumanity of Nothing: The Death of the Woman in the Kings County ER, Editorial by T. L. Kittle
11. The Doctors Channel Adds Esteemed Director of Minimally Invasive Urology at Columbia University to Editorial Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 One of the ... be a visit to Mount Kilauea on the big island. ... few places where you can see molten lava slowly oozing at ... on earth. , One place you would never expect ... the flat, arid terrain of Mission, Texas -- until now. , ...
(Date:3/31/2015)... Virginia (PRWEB) March 31, 2015 ... with Care Investment Trust LLC ("Care") a seniors ... Tiptree Financial Inc. Care announces today, their acquisition ... party seller for $54.48 million. Concurrent with the ... affiliates of Greenfield Senior Living ("Greenfield"). Pursuant to ...
(Date:3/31/2015)... The New Jersey Chapter of the ... two administrators from Windsor Healthcare Communities, a leading ... Jersey, to two key leadership roles at this ... administrator for Abingdon Care & Rehabilitation Center of ... administrator of Canterbury Care & Rehabilitation Center at ...
(Date:3/31/2015)... March 31, 2015 Tickets are now ... and Denver tradition since 1973. The 2015 Spring production, ... Showtime on Ice. On April 24 in partnership with ... and opening night tribute to the Pat Bowlen family, ... portion of the opening event proceeds will go to ...
(Date:3/31/2015)... March 31, 2015 Indiana Fiber ... Service Provider, announces that Joink, LLC selected IFN ... According to Cory Childs, IFN Enterprise Sales ... specifically targeted at Internet Service Providers, Telecom companies, ... service provides Joink with diverse protected transport from ...
Breaking Medicine News(10 mins):Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 3
... ARBOR, Mich. -- As the Diagnostic and Statistical Manual of ... controversy about psychiatric diagnosis is reaching a fever pitch. ... and depression, among others, are eliciting great concerns. However, there ... "Almost no one likes the DSM, but no one ...
... (HealthDay News) -- Babies can understand many words sooner than ... Researchers from the University of Pennsylvania say 6- to 9-month ... foods and body parts through their daily exposure to language. ... comprehension is possible until a child is closer to 1 ...
... Fla. February 15, 2012 Sanford-Burnham Medical ... returned from Japan where they reviewed the progress ... their research partnership with Takeda Pharmaceutical Company Limited ... and evaluation of new therapeutic approaches to obesity. ...
... Researchers from the University of Exeter, Peninsula College of ... the South Western Ambulance Service NHS Foundation Trust (SWASFT) ... Trust (RD&E) to reduce the time it takes from ... vital clot-busting drug treatment. The researchers are from ...
... Laser light in combination with certain drugs known as ... used mostly to cure skin cancer. The reason that internal ... technology does not exist to check that the precise amount ... atomic physics at Lund University in Sweden looks like being ...
... problems developing motor skills, such as running, throwing a ball ... known whether those difficulties run in families or are linked ... in St. Louis points to autism as the culprit. ... "From our results, it looks like motor impairments ...
Cached Medicine News:Health News:Psychiatric diagnoses: Why no one is satisfied 2Health News:Babies May Be Smarter Than You Think 2Health News:Sanford-Burnham and Florida Hospital review obesity research progress with Takeda Pharmaceutical 2Health News:Sanford-Burnham and Florida Hospital review obesity research progress with Takeda Pharmaceutical 3Health News:Operational research seeks benefit for stroke victims 2Health News:Operational research seeks benefit for stroke victims 3Health News:New method makes it easier to treat prostate and pancreatic cancer 2Health News:Autism affects motor skills, study indicates 2Health News:Autism affects motor skills, study indicates 3
(Date:3/31/2015)... PGI has announced an expansion of its ... at its San Luis Potosi, ... expansion is centered on solving the challenge of complicated ... personal care product manufacturers. The planned ... and packaging, will allow customers to take advantage of ...
(Date:3/31/2015)... , March 31, 2015  InMed Pharmaceuticals Inc. ... biopharmaceutical company that specializes in developing safer, more ... Paul C. Anderson , Ph.D., to its ... industry veteran who brings significant drug discovery and ... is a synthetic organic chemist by training with ...
(Date:3/31/2015)... March 31, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated ... overall US market for Propafenone Hydrochloride 150mg, 225mg and ... Health. Arthur S. Przybyl , President ... announce the launch of our fourth product from the ...
Breaking Medicine Technology:PGI Expands Manufacturing Capabilities At Mexico Plant 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3
... ofatumumab has activity in heavily pre-treated patients who have ... , PHILADELPHIA, Dec. 8 ... positive results from a pivotal trial pre-planned interim analysis ... lymphocytic leukemia (CLL). The results demonstrate the potential of ...
... Dec. 8 Alexion Pharmaceuticals,Inc. (Nasdaq: ... from AEGIS, an open-label,registration study examining Soliris(R) ... hemoglobinuria (PNH). The pre-specified,primary efficacy endpoint of ... 86,percent reduction (P<0.001). Key secondary endpoints including ...
Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
Bimod, acetabular cup "Xl" UHMWHDPE....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Duraloc acetabular cup system....
Medicine Products: